Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

8 Nov 2013 13:08

Tate & Lyle PLC – 8 November 2013

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) has been informed that Tim Lodge, an Executive Director of the Company, today exercised the following nil-cost options over ordinary shares of 25 pence each (“Shares”) under the Company’s Performance Share Plan 2003 (“PSP”) and Group Bonus Plan (“GBP”):

Type of award Date of award No of nil-cost options exercised

No of Shares sold to pay for tax and sale costs

PSP 19 June 2008 26,088 12,305
PSP 8 July 2009 151,999 71,690
PSP 10 August 2010 223,381 105,358
GBP 24 May 2011 51,683 24,377

The Shares were sold at 788.00 pence per Share on the London Stock Exchange. The balance of the shares was retained and Mr Lodge now has an interest in 298,510 Shares.

Mr Lodge’s holding exceeds the requirements of the Company’s Executive Shareholding Policy.

This notification is made in accordance with Paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Lucie GilbertCompany Secretary8 November 2013

Copyright Business Wire 2013

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.